Home › Crohn's Disease › Indiana › Indianapolis

Pag-aaral pangklinika para sa Crohn's Disease sa Indianapolis, IN

Isang pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Indianapolis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Nagre-recruitPhase 3

Indiana University Health University Hospital ( Site 5022), Indianapolis

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Nagre-recruitPhase 2

Indiana University Health University Hospital /ID# 278129, Indianapolis

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Nagre-recruitPhase 3

Riley Hospital for Children, Indianapolis

Edad 3 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06663332

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2/3

IU Health University Hospital, Indianapolis

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Nagre-recruitPhase 3

Indiana University Health University Hospital, Indianapolis

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Indiana University Health Riley Hospital for Children /ID# 256454, Indianapolis

Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05995353

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Nagre-recruitPhase 3

Riley Childrens Hospital, Indianapolis

Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05509777

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Indiana University Health Riley Hospital for Children /ID# 262215, Indianapolis

Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Nagre-recruitPhase 4

Riley Hospital for Children at Indiana University Health, Indianapolis

Edad 6 hanggang 17 · Lahat ng kasarian · Na-update May 27, 2026 · NCT05781152

Precise Infliximab Exposure and Pharmacodynamic Control

Nagre-recruitPhase 2/3

Riley Hospital for Children, Indianapolis

Edad 6 hanggang 22 · Lahat ng kasarian · Na-update May 5, 2026 · NCT05660746

Pag-aaral para sa Crohn's Disease sa ibang lungsod

Iba pang pag-aaral sa Indianapolis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.